Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020
Jeffrey J. Kooijman, Wilhelmina E. van Riel, Jelle Dylus, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9

Showing 9 citing articles:

Selective CK1α degraders exert antiproliferative activity against a broad range of human cancer cell lines
Gisele Nishiguchi, Lauren G. Mascibroda, Sarah M. Young, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
NTRK gene fusion testing and management in lung cancer
Matteo Repetto, Marina Chiara Garassino, Herbert H. Loong, et al.
Cancer Treatment Reviews (2024) Vol. 127, pp. 102733-102733
Open Access | Times Cited: 5
CellEKT: a robust chemical proteomics workflow to profile cellular target engagement of kinase inhibitors
Joel Rüegger, Berend Gagestein, Antonius P. A. Janssen, et al.
Molecular & Cellular Proteomics (2025), pp. 100961-100961
Open Access
Case report: Osimertinib administration during pregnancy in a woman with advanced EGFR-mutant non-small cell lung cancer
Pamela Soberanis Pina, Luis Lara‐Mejía, Venecia Matías-Cruz, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations
Eranga R. Balasooriya, Qibiao Wu, Haley Ellis, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 10, pp. 2181-2192
Closed Access | Times Cited: 1
The combination of PAC-1 and entrectinib for the treatment of metastatic uveal melanoma
Matthew W. Boudreau, Emily J. Tonogai, Claire P. Schane, et al.
Melanoma Research (2023)
Closed Access | Times Cited: 3
High-dose short-term osimertinib treatment is effective in patient-derived metastatic colorectal cancer organoids
Kirti K. Iyer, Dennis Poel, Anne Miggelenbrink, et al.
BJC Reports (2024) Vol. 2, Iss. 1
Open Access
Lung cancer and pregnancy
А. Л. Чернышова, A. A. Chernyаkov, Ju. M. Trushjuk, et al.
PULMONOLOGIYA (2024) Vol. 34, Iss. 4, pp. 544-551
Open Access
Rationally Designed Potent and Selective CK1α Degraders Exert Antiproliferative Activity Against a Broad Range of Human Cancer Cell Lines
Zoran Ranković, Gisele Nishiguchi, Sherif Abdelhamed, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top